Immune system recognizing vaccine antigens

The immune system's recognition of vaccine antigens is a complex physiological process rather than a single molecular target. It begins when vaccine-derived antigens are internalized by professional antigen-presenting cells (APCs) such as dendritic cells (NIH, 2023). These APCs process the antigens into smaller peptides and present them on the cell surface via Major Histocompatibility Complex (MHC) molecules (StatPearls, 2023). T-cell receptors (TCRs) on naive T-cells recognize these MHC-peptide complexes, initiating cellular immune responses (PubMed, 2022). Concurrently, B-cells recognize intact antigens through their B-cell receptors (BCRs), leading to their activation and the production of specific antibodies (CDC, 2023). This coordinated effort results in the formation of long-lived memory B and T cells, which provide rapid protection upon subsequent exposure to the actual pathogen (Nature, 2021). While this process is the target of all vaccination strategies, it involves a vast array of receptors, cytokines, and cell types rather than a single druggable site. Therapeutic interventions like adjuvants are used to enhance this recognition and subsequent immune response (NIH, 2023). Understanding the nuances of this recognition is essential for the design of next-generation vaccines against infectious diseases and cancer.

Other names

Vaccine-induced immune responseAntigen recognitionAdaptive immunity to vaccinationImmunological recognition of vaccine antigens

Activation of the innate and adaptive immune systems through the presentation of vaccine-derived antigens by MHC molecules to T-cells and the direct activation of B-cells, leading to antibody production and immunological memory.